Amy L. Flaxman
Oxford, ENG OX37DQ, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Phase I/IIa study to assess the safety, immunogenicity and efficacy of ChAdOx1-MVA vectored vaccines expressing a novel liver-stage malaria dual antigen LS2 by sporozoite challenge in malaria-naïve adults.
Journal: Wellcome open research
Published: March 19, 2026
Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A Vaccine.
Journal: The New England journal of medicine
Published: October 29, 2025
Evaluation of Salmonella Paratyphi specific antibody quantity and function after vaccination and controlled human infection.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: July 08, 2025
Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruse.
Journal: PLoS pathogens
Published: November 15, 2023
The safety and immunogenicity of a bivalent conjugate vaccine against Salmonella enterica Typhi and Paratyphi A in healthy Indian adults: a phase 1, randomised, active-controlled, double-blind trial.
Journal: Lancet (London, England)
Published: August 19, 2023
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials.
Journal: Clinical and experimental immunology
Published: November 01, 2022
Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial.
Journal: EBioMedicine
Published: May 03, 2022
An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females.
Journal: EBioMedicine
Published: January 11, 2022
Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses.
Journal: bioRxiv : the preprint server for biology
Published: January 04, 2022
Last Updated: 09/26/2026